Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 6235-6244

  Cruise, Michael W ^a,b   Lukens, John R ^a,b   Nguyen, Aileen P ^a   Lassen, Matthew G ^a,b   Waggoner, Stephen N ^a,b   Hahn, Young S ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOKINE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS; HEPATITIS C VIRUS; INFLAMMATION; LIVER INJURY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 33646524755     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.6235     Document Type: Article

References (56)

1. + T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. USA 96: 5692-5697.
2. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3: 51-62.
3. + T cells in the liver. J. Immunol. 172: 5222-5229.
4. Janssen, O., J. Qian, A. Linkermann, and D. Kabelitz. 2003. CD95 ligand-death factor and costimulatory molecule? Cell Death Differ. 10: 1215-1225.
5. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235.
6. Sakata, K., A. Sakata, N. Vela-Roch, R. Espinosa, A. Escalante, L. Kong, T. Nakabayashi, J. Cheng, N. Talal, and H. Dang. 1998. Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes. Eur. J. Immunol. 28: 2648-2660.
7. Pimentel-Muinos, F. X., and B. Seed. 1999. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11: 783-793.
8. Desbarats, J., and M. K. Newell. 2000. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat. Med. 6: 920-923.
9. Neff, T. A., R. F. Guo, S. B. Neff, J. V. Sarma, C. L. Speyer, H. Gao, K. D. Bernacki, M. Huber-Lang, S. McGuire, L. M. Hoesel, et al. 2005. Relationship of acute lung inflammatory injury to Fas/FasL system. Am. J. Pathol. 166: 685-694.
10. Garcia-Lopez, M. A., F. Sanchez-Madrid, J. M. Rodriguez-Frade, M. Mellado, A. Acevedo, M. I. Garcia, J. P. Albar, C. Martinez, and M. Marazuela. 2001. CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab. Invest. 81: 409-418.
11. Farber, J. M., and M. Bernhard. 2003. CXCR3. In Cytokine Reference. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 2003-2008.
12. Luster, A. D. 2003. MIG. In Cytokine Reference. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 1111-1118.
13. Farber, J. M. 2003. IP-10. In Cytokine Reference. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 1103-1110.
14. Blanpain, C. P., and M. Parmentier. 2003. CCR5. In Cytokine Reference. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 2067-2080.
15. Bernhard, M. 2003. CXCR4. In Cytokine Reference. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 2009-2018.
16. Mackay, C. R. 2003. CCR3. In Cytokine Reference. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 2055-2062.
17. Wang, J. T., J. C. Sheu, J. T. Lin, T. H. Wang, and D. S. Chen. 1992. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J. Infect. Dis. 166: 1167-1169.
18. Muller, H., E. Pfaff, T. Gocser, B. Kallinoski, C. Solbach, and L. Theilmann. 1993. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J. Gen. Virol. 74: 669-676.
19. Bronowicki, J. P., M. A. Loriot, V. Thiers, Y. Grignon, A. L. Zignego, and C. Brechot. 1998. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 28: 211-218.
20. Soguero, C., M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn. 2002. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J. Virol 76: 9345-9354.
21. + T cells by HCV core induces T cell-dependent hepatic inflammation. J. Leukocyte Biol. 78: 412-425.
22. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Stricter. 2002. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J. Immunol. 169: 1037-1049.
23. + T cells is Fas dependent. J. Immunol. 167: 6654-6662.
24. Schaub, F. J., W. C. Liles, N. Ferri, K. Sayson, R. A. Seifert, and D. F. Bowen-Pope. 2003. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase-calpain-dependent release of interleukin-1α. Circ. Res. 93: 515-522.
25. Marra, F., R. G. Romanelli, C. Giannini, P. Failli, S. Pastacaldi, M. C. Arrighi, M. Pinzani, G. Laffi, P. Montalto, and P. Gentilini. 1999. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29: 140-148.
26. Guo, Z., M. Zhang, H. Tang, and X. Cao. 2005. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood 106: 2033-2041.
27. + T cells. Proc. Natl. Acad. Sci. USA 97: 1707-1712.
28. Park, D. R., A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles. 2003. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 170: 6209-6216.
29. Ma, Y., H. Liu, H. Tu-Rapp, H. J. Thiesen, S. M. Ibrahim, S. M. Cole, and R. M. Pope. 2004. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat. Immunol. 5: 380-387.
30. Shimada, M., A. Andoh, Y. Araki, Y. Fujiyama, and T. Bamba. 2001. Ligation of the Fas antigen stimulates chemokine secretion in pancreatic cancer cell line PANC-1. J. Gastroenterol. Hepatol. 16: 1060-1067.
31. Dosreis, G. A., V. M. Borges, and W. A. Zin. 2004. The central role of Fas-ligand cell signaling in inflammatory lung diseases. J. Cell. Mol. Med. 8: 285-293.
32. Rotondi, M., E. Lazzeri, P. Romagnani, and M. Serio. 2003. Role for interferon-γ inducible chemokines in endocrine autoimmunity: an expanding field. J. Endocrinol Invest. 26: 177-180.
33. Gerard, C., and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2: 108-115.
34. Bieche, I., T. Asselah, I. Laurendeau, D. Vidaud, C. Degot, V. Paradis, P. Bedossa, D. C. Valla, P. Marcellin, and M. Vidaud. 2005. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 332: 130-144.
35. Harvey, C. E., J. J. Post, P. Palladinetti, A. J. Freeman, R. A. Ffrench, R. K. Kumar, G. Marinos, and A. R. Lloyd. 2003. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and tabular inflammation. J. Leukocyte Biol. 74: 360-369.
36. Helbig, K. J., A. Ruszkiewicz, L. Semendric, H. A. Harley, S. R. McColl, and M. R. Beard. 2004. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 39: 1220-1229.
37. Itoh, Y., A. Morita, K. Nishioji, S. Narumi, T. Toyama, Y. Daimon, H. Nakamura, T. Kirishima, and T. Okanoue. 2001. Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J. Viral Hepat. 8: 341-348.
38. Butera, D., S. Marukian, A. E. Iwamaye, E. Hembrador, T. J. Chambers, A. M. Di Bisceglie, E. D. Charles, A. H. Talal, I. M. Jacobson, C. M. Rice, and L. B. Dustin. 2005. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 106: 1175-1182.
39. Xanthou, G., T. J. Williams, and J. E. Pease. 2003. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Eur. J. Immunol. 33: 2927-2936.
40. Heise, C. E., A. Pahuja, S. C. Hudson, M. S. Mistry, A. L. Putnam, M. M. Gross, P. A. Gottlieb, W. S. Wade, M. Kiankarimi, D. Schwarz, et al. 2005. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J. Pharmacol. Exp. Ther. 313: 1263-1271.
41. Itoh, Y., A. Morita, K. Nishioji, H. Fujii, H. Nakamura, T. Kirishima, T. Toyama, N. Yamauchi, Y. Nagao, S. Narumi, and T. Okanoue. 2001. Time course profile and cell-type-specific production of monokine induced by interferon-γ in Concanavalin A-induced hepatic injury in mice: comparative study with interferon-inducible protein-10. Scand. J. Gastroenterol. 36: 1344-1351.
42. Romagnani, P., F. Annunziato, L. Lasagni, E. Lazzeri, C. Beltrame, M. Francalanci, M. Uguccioni, G. Galli, L. Cosmi, L. Maurenzig, et al. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107: 53-63.
43. Bonacchi, A., P. Romagnani, R. G. Romanelli, E. Efsen, F. Annunziato, L. Lasagni, M. Francalanci, M. Serio, G. Laffi, M. Pinzani, et al. 2001. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem. 276: 9945-9954.
44. Apolinario, A., P. L. Majano, R. Lorente, O. Nunez, G. Clemente, and C. Garcia-Monzon. 2005. Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J. Viral Hepat. 12: 27-37.
45. Machida, K., K. Tsukiyama-Kohara, E. Seike, S. Tone, F. Shibasaki, M. Shimizu, H. Takahashi, Y. Hayashi, N. Funata, C. Taya, et al. 2001. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J. Biol. Chem. 276: 12140-12146.
46. Ray, R. B., K. Meyer, and R. Ray. 1996. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226: 176-182.
47. Gremion, C., B. Grabscheid, B. Wolk, D. Moradpour, J. Reichen, W. Pichler, and A. Cerny. 2004. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J. Virol. 78: 2152-2157.
48. Mahalingam, S., J. M. Farber, and G. Karupiah. 1999. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73: 1479-1491.
49. Mihm, S., S. Schweyer, and G. Ramadori. 2003. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-γ and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J. Med. Virol. 70: 562-570.
50. Ahmad, A., and F. Alvarez. 2004. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukocyte Biol. 76: 743-759.
51. Whiting, D., G. Hsieh, J. J. Yun, A. Banerji, W. Yao, M. C. Fishbein, J. Belperio, R. M. Stricter, B. Bonavida, and A. Ardehali. 2004. Chemokine monokine induced by IFN-γ/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J. Immunol. 172: 7417-7424.
52. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204.
53. Eichhorst, S. T., A. Krueger, S. Muerkoster, S. C. Fas, A. Golks, U. Gruetzner, L. Schubert, C. Opelz, M. Bilzer, A. L. Gerbes, and P. H. Krammer. 2004. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat. Med. 10: 602-609.
54. Doggrell, S. A. 2004. Suramin: potential in acute liver failure. Expert Opin. Investig. Drugs 13: 1361-1363.
55. Yang, Y. F., T. Mukai, P. Gao, N. Yamaguchi, S. Ono, H. Iwaki, S. Obika, T. Imanishi, T. Tsujimura, T. Hamaoka, and H. Fujiwara. 2002. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur. J. Immunol. 32: 2124-2132.
56. Ondeykal, J. G., K. B. Herath, H. Jayasuriya, J. D. Polishook, G. F. Bills, A. W. Dombrowski, M. Mojena, G. Koch, J. DiSalvo, J. DeMartino, et al. 2005. Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3. Mol. Divers. 9: 123-129.